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Abstract
Objective: To investigate whether the 5/6 nephrectomized (5/6Nx) rats’ 12-week serum could lead to tubular epithelial-
to-mesenchymal transition (EMT) and its molecular mechanism, so as to probe the potential stimulation from circulation
in chronic progressive kidney disease. Methods: A total of 24 Sprague Dawley (SD) rats were randomly divided into
two groups: sham operation group (sham group) and 5/6Nx group. Rats were killed 12 weeks after surgery to obtain
5/6Nx rats’ 12-week serum. Then we detected the expression of E-cadherin in renal tubular epithelial cells of the
remaining kidney and we investigated whether the 12th week serum of 5/6Nx rats could cause HK-2 (human kidney
proximal tubular cell line) cells to transdifferentiate into ﬁbroblasts. Results: Our data conﬁrmed that E-cadherin expres-
sion decreased signiﬁcantly in the remaining kidney at 12 weeks, and the 5/6Nx rats’ 12-week serum could suppress
E-cadherin protein and mRNA expression (p < 0.05). We also found that the 5/6Nx rats’ 12-week serum could upreg-
ulate ZEB1, β-catenin, and wnt3 protein expression (p < 0.05). Conclusions: Our results demonstrated that the 5/6Nx
rats’ 12-week serum could suppress the expression of E-cadherin in HK-2 cells. It was partially through modulating the
increase of ZEB1. The loss of E-cadherin could lead β-catenin to localize to the cytoplasm and nucleus, and feed into
the Wnt signaling pathway. It means that the pathogenic serum in chronic kidney disease (CKD) plays an important role
in the loss of renal function and turns to be a new avenue of research with potential clinical implications.
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INTRODUCTION
Renal ﬁbrosis is the principal process underlying
the progression of chronic kidney disease (CKD) to
end-stage renal disease (ESRD).1 It involves glomeru-
losclerosis and tubulointerstitial ﬁbrosis. However,
tubulointerstitial ﬁbrosis has evolved as the most con-
sistent predictor of an irreversible loss of renal func-
tion and progression to ESRD. Recent studies have
demonstrated that a critical step in the pathogenesis of
tubulointerstitial ﬁbrosis is epithelial-to-mesenchymal
transition (EMT),2,3 whereby renal tubular epithelial
cells change phenotypically and functionally into myoﬁ-
broblasts. Activation of tubulointerstitial myoﬁbroblast
leads to the production of excessive extracellular matrix
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with a predominance of interstitial collagens and plays a
critical role in the progression of CKDs.4
A number of factors may initiate EMT in kidney dis-
ease. Much is known about the molecular background
of ﬁbrosis that the growth factors and cytokines, includ-
ing transforming growth factor-β (TGF-β), ﬁbrob-
last growth factor (FGF), interleukin-1 (IL-1), epi-
dermal growth factor (EGF), and angiotensin II,5–9
prompt ﬁbroblasts or transdifferentiate kidney cells to
release collagen and matrix components.10 However,
the growth factors and cytokines mainly take effect
through local autocrine and paracrine.
In CKD patients, with the decrease in glomerular ﬁl-
tration rate, the excretion of metabolites fails. The body
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also undergoes oxidative stress, carboxyl shock, micro-
inﬂammation, and other pathological and physiological
changes,11,12 where some metabolic toxins are accu-
mulated in the body. The endocrine system in CKD
patients is also abnormal, such as abnormal circulating
renin-angiotensin-aldosterone system (RAS) together
with a variety of vasoactive substances mediating renal
injury.13 Therefore, it is of great importance to probe
the stimulation from circulation in chronic progressive
kidney disease.
The 5/6 nephrectomized (5/6Nx) rat model is
the most typical model for CKD study. After 5/6
nephrectomy, the remnant kidney initiates inﬂammation
to repair the injured kidney. Then, the remnant kid-
ney unit has a disturbance in hemodynamics, with high
perfusion, high ﬁltration, and high pressure. This dis-
turbance results in scar repair of the injured nephrons
and compensatory hypertrophy, hyperplasia, and scle-
rosis of the remnant nephrons. Ultimately the remnant
kidney manifests as progressive renal dysfunction and
accumulates metabolic toxins.14
Prior to our experiment, we took an overall review of
the dynamic changes of renal pathological morphology
in the 5/6Nx rat model. It was shown that glomerular
sclerosis and tubulointerstitial ﬁbrosis, which were simi-
lar to the pathologic situation of the majority of CKD
patients, were hardly identiﬁed at the 8th week after
nephrectomy, but were apparent at the 12th week.15 We
can assume that the experimental kidney compensated
for 8 weeks, but never for 12 weeks. It should be worse
at the 16th week. Our research aimed to explore any
potential pathologic stimulation from circulation sys-
tem at an early stage, so we employed the serum at
the 12th week as the pathological stimulation. EMT is
believed to be a promising mechanism, so we chose it as
the entry point of research, by exerting the 5/6Nx rat
serum to HK-2 (human kidney proximal tubular cell
line) cell culture and investigated whether this serum
could lead renal tubular epithelial cells to mesenchymal
transition and its molecular mechanism. It would help
to ascertain the potential stimulation from circulation in
chronic progressive kidney disease.
MATERIALS AND METHODS
Animals and Establishment of 5/6 Nephrectomized Rat
Model
A total of 24 speciﬁed pathogen-free male Sprague
Dawley (SD) rats at 3 months of age were used for
this study. Each rat was housed in our animal facility
under pathogen-free conditions and fed a standard
laboratory diet, with free access to water. The temper-
ature was maintained at 18–22◦C with 12 h light/dark
cycle. All animal procedures complied with published
recommendations for use of laboratory animals by the
government. On the day of the operation, the 24 SD
rats were randomly divided into two groups: 5/6Nx
group (5/6Nx, n = 12) and sham operation group
(sham, n = 12). All rats were anesthetized with 2%
pentobarbital sodium (30 mg/kg body weight, intraperi-
toneally). Renal mass reduction (n = 12) was obtained
by ablation of two-thirds mass of the left kidney and
subsequent right unilateral nephrectomy 1 week later.
For the sham operation group rats a laparotomy was
performed and the renal pedicle manipulated without
any removal of renal mass.
After 12 weeks, serum was sampled from abdomi-
nal aorta followed by complement heat inactivation at
56◦C × 30 min. Then the serum was sterilized by pass-
ing it through a 0.22 μm ﬁlter and stored at −80◦C.
The remnant kidney was decapsulated and divided into
several parts. One part was ﬁxed in 4% paraformalde-
hyde/phosphate buffered saline (PBS) and processed
for histological analysis, while another part was ﬁxed
in optimum cutting temperature (OCT) compound,
quickly frozen in liquid nitrogen, and stored at −80◦C
for immunoﬂuorescence (IF) analysis. The remaining
parts were dissected to isolate the kidney, which was
quickly frozen in liquid nitrogen and stored at −80◦C
for protein extraction.
Serum creatinine and blood urea nitrogen (BUN)
were measured with auto-biochemical analyzer
(Hitachi QA36, Tokyo, Japan).
Renal Morphologic Studies
Kidney slices 3–4 mm in thickness were ﬁxed in buffered
10% formalin phosphate and embedded in parafﬁn.
S e c t i o n so f2μm thickness were prepared and stained
with periodic acid-Schiff (PAS) and Masson trichrome
staining. Glomerular sclerotic injury was deﬁned as seg-
mental accumulation of glomerular matrix and segmen-
tal or global collapse of glomerular capillaries with depo-
sition of hyalin and adhesion of the tuft to Bowman’s
membrane.16 Tubulointerstitial injury was deﬁned as
tubular atrophy, dilation, intratubular casts, thickening
of tubular basement membrane, cellular inﬁltration, and
widening of the interstitium.
Tissue Immunoﬂuorescence Staining
Frozen sections of 4 μm thickness were prepared and
washed with PBS twice for 10 min and preincubated in
10% casein (Vector, Burlingame, CA, USA) in PBS for
30 min. The sections were incubated in E-cadherin anti-
body overnight in a moisture chamber and then washed
sufﬁciently with phosphate buffer saline–Tween (PBST)
to remove unbound antibody. Next, the sections were
incubated with cy3-conjugated anti-rabbit IgG antibody
(Jackson ImmunoResearch, Baltimore, PA, USA) for 60
min at room temperature and washed as described for
the primary antibody. The sections were mounted on
glass slides and analyzed under an Olympus EX71 ﬂuo-
rescence microscope equipped with an Olympus DP72
digital camera (Olympus, Tokyo, Japan).
Cell Culture and Treatment
The human kidney proximal tubular cell line
(HK-2, ATCC, Manassas, VA, USA) was cultured
in Dulbecco’s modiﬁed Eagle medium (DMEM)/F12
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(Invitrogen, Carlsbad, CA, USA), containing 2.50 g/L
4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES) (Sigma, St. Louis, MO, USA), 1.80 g/L
sodium bicarbonate (Sigma), 100 U/mL penicillin, 100
U/mL streptomycin (Invitrogen), and 10% fetal bovine
serum (FBS) (Invitrogen) at 37◦Ci n5 %C O 2.
After digesting with 0.25% trypsin (Invitrogen),
2 × 105 cells were grown in 25 cm2 plastic culture
bottles. For experiments, HK-2 cells were cultured in
DMEM/F12 10% FBS overnight and in DMEM/F12
0.1% FBS for 16 h. Then the media were changed in the
following manner: DMEM/F12 10% FBS; DMEM/F12
10% sham operation serum; DMEM/F12 10% 5/6Nx
rats’ 12-week serum. Cultures were continued for a
further 48 h.
Morphological Assessment of HK-2 Cells
The cells were washed twice with PBS and pho-
tographed using an Olympus EX71 ﬂuorescence micro-
scope equipped with an Olympus DP72 digital camera.
Length/breadth ratios were used to quantify morpholog-
ical changes.17 For each group of cultured cells, 80 cells
were measured.
Cell Immunoﬂuorescence Microscopy
For indirect IF, cells were ﬁxed in 4% paraformalde-
hyde in PBS for 10 min at 37◦C, washed with PBS
for 10 min, then permeabilized with ice-cold Triton
buffer (0.5% Triton X-100 in 20 mM HEPES, 50 mM
NaCl, 3 mM MgCl2, 300 mM sucrose) for 5 min on
ice, blocked with 1% bovine serum albumin in PBS for
10 min on ice, and incubated with primary antibod-
ies overnight in a moisture chamber. It was sufﬁciently
washed with PBST to remove unbound antibodies.
Secondary antibodies labeled with ﬂuoresceinisothio-
cyanate (FITC) or cy3 (Jackson ImmunoResearch)
were incubated for 60 min at room temperature and
washed as with the primary antibodies. Glass cover slips
carrying the treated cells were mounted with the cytosol
mounting medium onto glass slides and analyzed under
an Olympus EX71 ﬂuorescence microscope equipped
with an Olympus DP72 digital camera.
Western Blotting
Kidney tissues or cultured cells were lysed in radio-
immunoprecipitation assay (RIPA) buffer that was com-
posed of 1 μg/mL leupeptin, 1 μg/mL aprotinin,
and 100 μM phenylmethanesulfonyl ﬂuoride (PMSF).
All samples were spun (12,000 rpm) for 30 min at
4◦C, and the protein concentration in each lysate
was determined by BCA Protein Assay Kit. A total
of 50 μg protein was separated by 6–10% SDS-
PAGE and then transferred to a membrane which
was then blocked with 5% skim milk, probed with
a primary antibody at 4◦C overnight, and afterward
incubated with a horseradish peroxidase-conjugated
secondary antibody. Antibody for E-cadherin was pro-
cured from Abcam (Cambridge, UK). Antibodies for
vimentin, wnt3, β-catenin, and ZEB-1 were procured
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA,
USA). Antibody for β-actin was from Sigma. Finally,
immunoreactive bands were visualized using enhanced
chemiluminescence (ECL) reagent and exposed to X-
ray ﬁlm. Protein band intensities were quantiﬁed using
Quantity One software (Bio-Rad, Hercules, CA, USA).
Reverse Transcription-PCR Analysis
Total RNA was isolated using TRIzol (Invitrogen), and
cDNA was synthesized with 5 mg total RNA in a reac-
tion volume of 25 μL containing 0.5 μL oligonucleotide
(dT); 20 mM dNTPs; 0.5 μL RNasin; 0.1 M DTT;
5 μL buffer; and 1 μL M-MLV reverse transcriptase
(Gibco BRL, Gaithersburg, MD, USA). The ﬁnal RT
product mix of 1 μL was then ampliﬁed with PCR.
Primers for RT-PCR were as follows:
Human
E-cadherin
Sense: 5 -CGC CCT ATG ATT CTC TGC
TCG-3 
Antisense: 5 -TCG TCC TCG CCG CCT
CCG TA-3 
Human
vimentin
Sense: 5 -TTG AAC GCA AAG TGG AAT
C-3 
Antisense: 5 -AGG TCA GGC TTG GAA
ACA-3 
Human
ﬁbronectin
Sense:
5 -TGAGAAGCCTGGGTCTCCTCC-3 
Antisense: 5 -
TTGGGGAAGCTCGTCTGTCTTT-3 
Human
GAPDH
Sense: 5 -AAC GAC CCC TTC ATT
GAC-3 
Antisense: 5 -TCC ACG ACA TAC TCA
GCA C-3 
The annealing temperatures were 58◦Cf o r
E-cadherin, ﬁbronectin, and GAPDH and 56◦C
for vimentin. The number of PCR cycles used was
35 for all genes. The PCR products were resolved
by electrophoresis in 1.5% agarose gel (Gibco BRL),
stained with ethidium bromide, and visualized under
ultraviolet light.
Statistics
All data analyses were performed with SPSS 11.0
(SPSS Inc., Chicago, IL, USA) software. Descriptive
statistics are presented as means and standard devia-
tion (mean ± SD). Comparisons among groups were
conducted with ANOVA. p-Value less than 0.05 was
considered signiﬁcant.
RESULTS
Serum Creatinine and Blood Urea Nitrogen Level
At the end of 12 weeks after the surgery, serum creati-
nine and BUN were higher in 5/6Nx rats than in sham
operation rats (p < 0.01 vs. sham group, Table 1).
Renal Histopathology
The histopathological alterations in the glomeruli and
tubulointerstitium were evaluated by microscopical
examination of the sections stained with PAS and
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Table 1. Serum creatinine and blood urea nitrogen level.
Groups Scr (μmol/L) BUN (mmol/L)
Sham 17.60 ± 4.51 7.76 ± 0.87
5/6Nx 65.02 ± 25.76∗ 15.24 ± 6.45∗
Notes: Sham, sham operation group; 5/6Nx, 5/6 nephrectomized
group; BUN, blood urea nitrogen; Scr, Serum creatinine.
∗Denotes p < 0.01 versus sham group.
Masson trichrome staining. Rats of sham operation
groups showed normal glomerular and tubulointersti-
tial morphology. 5/6Nx rats showed segmental sclerosis
of remnant glomeruli, enlargement of tubular lumen,
protein cast, tubular atrophy, interstitial expansion
accompanied by numerous inﬁltrations of mononuclear
cells and interstitial ﬁbrosis (Figure 1).
According to the serum creatinine, BUN level, and
renal histopathology, we could deﬁne that the 5/6Nx
rat models were established successfully, thus the 5/6Nx
rats’ 12-week serum was qualiﬁed for the experiment.
Expression of E-Cadherin in Renal Tubular Epithelial
Cells of the Remaining Kidney
E-Cadherin was expressed in most of the tubular epithe-
lial cells of the rats in the sham operation group, while
it was decreased signiﬁcantly in the remaining kidney at
12 weeks (p < 0.05, Figure 2), by Western blot analyses
and IF staining.
Morphological Assessment of HK-2 Cells
To investigate whether the 5/6Nx rat serum could
inﬂuence the morphology of HK-2 cells, microscope
was used; 10% FBS and 10% sham serum groups
(A1)
(B1)
(B4)
(A4) (A5) (A6)
(B5) (B6)
(A2) (A3)
(B2) (B3)
Figure 1. Pathological ﬁndings in 5/6 nephrectomized rats (periodic acid-Schiff (PAS) staining and Masson staining). (A1–A3) Sham
group (PAS staining). (B1–B3) 5/6 nephrectomized group (PAS staining). (A4–A6) Sham group (Masson staining). (B4–B6) 5/6 nephrec-
tomized group (Masson staining). The arrow points indicate glomerular sclerosis, inﬂammatory cell inﬁltration of the interstitium, protein
casts, tubular atrophy, and interstitial ﬁbrosis.
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Figure 2. Expression of E-cadherin in kidney frozen sections
and tissues. (A) The localization of E-cadherin in frozen sections
was determined by IF (200×) with E-cadherin antibody (red).
(B) Western blot analysis of E-cadherin in kidney tissues. Lanes 1
and 2 are sham operation group and lanes 3 and 4 are 5/6Nx
group. (C) E-cadherin protein levels. Data were expressed versus
β-actin and compared with ANOVA.
Note: ∗Denotes p < 0.05 versus sham operation group.
showed typical cobblestone morphology of epithelial
cells, while the cell morphology changes after they
were treated for 48 h with 10% 5/6 nephrectomized
rat serum (5/6Nx). Cells became more elongated in
shape, disassociated from neighboring cells, and lost
their cobblestone monolayer pattern (Figure 3). Length/
breadth ratios for 5/6Nx rat serum group (3.97 ±
1.04) were signiﬁcantly greater than for FBS (1.35 ±
0.36) or sham operation serum groups (1.39 ± 0.41)
(p < 0.01,Table 2).
Table 2. Effect of 5/6 nephrectomized rat serum on mor-
phology of HK-2 cells (length/width ratio).
Group Cell length/width
FBS 1.35 ± 0.36
Sham serum 1.39 ± 0.41
5/6Nx serum 3.97 ± 1.04∗
Notes: Sham, sham operation group; 5/6Nx, 5/6 nephrec-
tomized group.
∗Denotes p < 0.01 versus 10% sham operation serum
group.
Effect of 5/6 Nephrectomized Rat Serum on Tubular
Epithelial-to-Mesenchymal Transition
IF, Western blot, and RT-PCR analysis were performed
in 10% FBS, 10% sham serum, and 10% 5/6Nx serum
group cells to detect the expression of E-cadherin,
vimentin, and ﬁbronectin in HK-2 cells (Figures 4–6).
As shown in Figures 4–6, the 5/6Nx rat serum could
suppress HK-2 cells expressing protein and mRNA of
E-cadherin (p < 0.05), though it seemed there was
no signiﬁcant effect on the expression of vimentin and
ﬁbronectin. We found that the 5/6Nx rat serum had a
time-dependent effect on the expression of E-cadherin
(Figure 7).
Effect of 5/6 Nephrectomized Rat Serum on the
Expression of ZEB1, β-Catenin, and wnt3 in HK-2 Cells
The expressions of ZEB1, β-catenin, and wnt3 were
detected by Western blot analysis. Our results showed
that compared with 10% FBS and 10% sham serum
groups, HK-2 cells incubated in 10% 5/6 nephrec-
tomized rat serum lead to the activation of ZEB1,
β-catenin, and wnt3 (Figure 8).
DISCUSSION
In this study, the effect of 5/6Nx rat serum on tubu-
lar EMT in vitro was detected. Our study demonstrated
that E-cadherin expression was decreased signiﬁcantly
in the remaining kidney at 12 weeks. With the 5/6Nx
rats’ 12-week serum treated for 48 h, E-cadherin mRNA
and protein levels of HK-2 cells were signiﬁcantly down-
regulated, though it seemed there was no signiﬁcant
effect on the expression of vimentin and ﬁbronectin. We
Figure 3. Morphological assessment of HK-2 cells. (A) 10% FBS group (100×); (B) 10% sham serum group (100×); (C) 10% 5/6
nephrectomized rat serum group (100×).
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Figure 4. Expression of E-cadherin, vimentin, and ﬁbronectin protein in cultured cells. The localization of E-cadherin, vimentin, and
ﬁbronectin was determined by IF (400×) with E-cadherin antibody (red) (A1–A3), vimentin antibody (green) (B1–B3), and ﬁbronectin
antibody (red) (C1–C3).
provided the evidence that 5/6Nx rat serum contributed
to the activation of ZEB1 and led to the activation of
Wnt signaling pathway.
In CKD patients, with the decrease in glomerular
ﬁltration rate, the excretion of metabolites failed. The
body also underwent oxidative stress, carboxyl shock,
micro-inﬂammation, and other pathological and physio-
logical changes. As a result, some metabolic toxins were
accumulated in the body, including advanced glyca-
tion products,18 advanced oxidation protein products,11
homocysteine,12 and so on. The endocrine system
in CKD patients also turns up some abnormali-
ties. Circulating RAS was active. Ang II hemody-
namically could signiﬁcantly increase blood pressure,
glomerular capillary pressure, and the permeability
of ﬁltration membrane, which promoted glomeru-
lar sclerosis and renal interstitial ﬁbrosis.13 It also
had non-hemodynamic effects, like increasing the
expression of TGF-β, chemokines, and the activ-
ity of macrophage. It also promoted the deposition
of extracellular matrix, cell proliferation, and tissue
remodeling.19
Accumulation of metabolic toxins from peritubu-
lar capillaries could stimulate renal tubular epithelial
cells and the abnormal endocrine system could affect
the adherence function of renal tubular epithelial cells
through glomerular and peritubular capillaries. In our
study, we ﬁrst demonstrated that E-cadherin expression
was decreased signiﬁcantly in the remaining kidney at
12 weeks. Then we conﬁrmed that 5/6Nx rats’ 12-week
serum, which was similar to the pathogenic serum of
CKD patients, could suppress the expression of inter-
cellular adhesion junction protein E-cadherin in HK-2
cells. In the present technology, we can hardly clarify the
constituents of the 5/6Nx rats’ 12-week serum. How-
ever, the mechanism we demonstrated should provide
us a new vision for the prevention and treatment of
CKD.
Downregulation of E-cadherin marks the initiation of
EMT.20 The most important event of EMT is the loss
of E-cadherin. E-Cadherin is a hallmark of epithelial
cell layers and is localized at the basolateral membrane
in adherens junctions. The core molecule of adherens
junctions, E-cadherin connects neighboring epithelial
cells by calcium-dependent homotypic interactions of its
extracellular tail.21
We found that 5/6Nx rat serum could downreg-
ulate E-cadherin mRNA and protein expressions in
HK-2 cells, considering this pathogenic serum regu-
lated the expression of E-cadherin in transcriptional
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Figure 5. Expression of E-cadherin, vimentin, and ﬁbronectin
in HK-2 cells. (A) Western blot of E-cadherin, vimentin, and
ﬁbronectin. Lanes 1–3 are 10% FBS group, 10% sham opera-
tion serum group, and 10% 5/6 nephrectomized rat serum group,
respectively. (B) E-cadherin, vimentin, and ﬁbronectin protein
levels. Data were expressed versus β-actin and compared with
ANOVA.
Notes: The experiment was repeated three times with similar
results.
∗Denotes p < 0.05 versus 10% sham operation serum group.
control. ZEB1 is a member of the ZEB family, which
is widely known as the member of E-cadherin transcrip-
tional repressors.22–24
ZEB1 can interact with DNA through the simul-
taneous binding of the two zinc-ﬁnger domains
to high-afﬁnity binding sites composed of bipartite
E-boxes (CACCT and CACCTG), as is found in
the E-cadherin promoter, and then suppress the syn-
thesis of the cell–cell adhesion protein.25 ZEB1 also
promotes EMT by repressing expression of basement
membrane components and cell polarity proteins.26
Our Western blot analysis results indicated that
ZEB1 was signiﬁcantly increased in 5/6Nx rat serum
group. We provided the evidence that the activa-
tion of ZEB1 contributed to the downregulation of
E-cadherin.
We found that the 5/6Nx rat serums have no sig-
niﬁcant effect on the expression of vimentin and
ﬁbronectin in HK-2 cells. However, downregulation of
E-cadherin has several important consequences which
are of direct relevance to EMT. The cytoplasmic part
of E-cadherin interacts with the other components of
adherens junctions, in particular β-catenin.27 The con-
sequence of a loss of E-cadherin is an impairment of
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Figure 6. E-Cadherin, vimentin, and ﬁbronectin mRNA in HK-2
cells. (A) Total RNA isolated from rats at different ages was ana-
lyzed with RT-PCR. Lanes 1–4 are marker (DL2000), 10% FBS
group, 10% sham operation serum group, and 10% 5/6 nephrec-
tomized rat serum group, respectively. (B) Expression analysis
of E-cadherin, vimentin, and ﬁbronectin mRNA abundance with
ANOVA.
Notes: The experiment was repeated three times with similar
results.
∗Denotes p < 0.05 versus 10% sham operation serum group.
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Figure 7. Expression of E-cadherin at different time points of
HK-2 cells. (A) Western blot analysis of E-cadherin in cultured
cells at different time points. (B) E-Cadherin protein levels. Data
were expressed versus β-actin and compared with ANOVA.
∗Denotes p < 0.05 versus sham operation serum group.
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Figure 8. Expression of wnt3, β-catenin, and ZEB1 in HK-2
cells. (A) Western blot analysis of wnt3, β-catenin, and ZEB1.
Lanes 1–3 are 10% FBS group, 10% sham operation serum
group, and 10% 5/6 nephrectomized rat serum group, respec-
tively. (B) wnt3, β-catenin, and ZEB1 protein levels. Data were
expressed versus β-actin and compared with ANOVA.
Notes: The experiment was repeated three times with similar
results.
∗Denotes p < 0.05 versus 10% sham operation serum group.
cell–cell adhesion, which allows detachment of cells.
E-Cadherin-mediated sequestering of β-catenin in the
cytoplasm is abolished and leads to nuclear localization
of β-catenin. β-Catenin has also been demonstrated to
play an important role in the induction of EMT. As
a result, β-catenin localizes to the nucleus and feeds
into the Wnt signaling pathway by activating tran-
scriptional regulation through LEF/TCF4 (lymphoid
enhancer-binding factor/T-cell factor-4).28
Our study showed that the expressions of β-catenin
and wnt3 were all upregulated. It indicated that
although the 5/6Nx rat serum could not lead the tubu-
lar epithelial cells to mesenchymal transition, it could
suppress the expression of E-cadherin. The loss of
E-cadherin led β-catenin to localize to the cytoplasm
and nucleus, while nuclear localization of β-catenin fed
into the Wnt signaling pathway. Wnt signaling is also
linked to EMT, by direct activation of snail or by indi-
rect activation of ZEB1 via other WNT target genes, for
example, COX229 or IGF1.30 Taken together, we found
that the 5/6Nx rat serum could lead the tubular cell
into this pathological loop involving E-cadherin, ZEB1,
and β-catenin. This pathological loop is the crucial
step of EMT.31 Interference with these crosstalks might
offer novel therapeutic opportunities in CKD in the
future.
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